Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
NCT04817215
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
608
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
ORMD-0801
Sponsor
King Hamad University Hospital, Bahrain
Collaborators
[object Object]
[object Object]